MSME (Udyam registered) Ministry of MSME
- Category
- Small (2022-23)
- Udyam number
- UDYAM-TN-30-0036296
Maxell Pharma Private Limited - pharma in Sriperumbudur, Tamil Nadu, India. FY 2026 financials & compliance.
Revenue · FY 2024
₹6.92 Cr
▲ 52% YoY
Net profit · FY 2024
₹27.37 Lakh
Net margin 4%
EBITDA · FY 2024
₹1.31 Cr
EBITDA margin 18.9%
Authorised capital
₹50 Lakh
Registered with MCA
Paid-up capital
₹42.25 Lakh
Issued & subscribed
Open charges
₹4.61 Cr
Secured borrowings
Company age
16 yrs
Est. 2010
Directors on board
6
As per MCA filings
About Maxell Pharma Private Limited
Data last updated:
Maxell Pharma Private Limited is a private limited company based in Sriperumbudur, Tamil Nadu, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 16 April 2010 and has been in existence for over 16 years.
The company is registered with the Registrar of Companies (ROC), Chennai, under CIN U24297TN2010PTC075380. Its GSTIN is 33AAHCM1539L1ZD (Tamil Nadu).
The company has an authorised share capital of ₹50 Lakh and a paid-up capital of ₹42.25 Lakh. It is led by directors including Shankar Subramanian (Managing Director) and Madhuram Senthil Kumar.
Its last annual general meeting (AGM) was held on 29 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Sriperumbudur, Tamil Nadu.
As per the financials filed for FY 2024, the company reported a revenue of ₹6.92 Cr, a growth of 52% compared to the previous year. For the same year it recorded a net profit of ₹27.37 Lakh (net margin 4%) and EBITDA of ₹1.31 Cr (EBITDA margin 18.9%). Revenue has grown at a compounded annual rate (CAGR) of 6% over three years and 5% over five years.
As per MCA filings, the company has open charges of ₹4.61 Cr on record. Court records list 2 cases involving the company, including 2 filed against it; 1 case is pending.
Maxell Pharma Private Limited is registered as a small enterprise under the Udyam registration framework (Reg. No. UDYAM-TN-30-0036296). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website maxellpharma.com.
Company details
CIN U24297TN2010PTC075380
Registration Number 075380
Incorporation Date 16 April 2010
ROC Chennai
Listing Status Unlisted
Company Status Active
Date of Last AGM 29 September 2025
Date of Balance Sheet 31 March 2025
Compliance Status Active Compliant
MSME Classification Small
Udyam Registration UDYAM-TN-30-0036296
Key People
Shankar Subramanian Managing Director Madhuram Senthil Kumar Director Madhuram Udhaya Chander Director Recognitions & Rankings of Maxell Pharma
Contact details
Maxell Pharma Private Limited's registered office is in Sriperumbudur, Tamil Nadu. Its website is maxellpharma.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Registered AddressNo. 63 64 70 & 71 Second Floor, Vgn Highness Rajendravarma Street Srinivasapuram, Sriperumbudur, Tamil Nadu, India – 600056
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Maxell Pharma Private Limited, buy the company report.
Comprehensive company report
Maxell Pharma Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Business activity
The main business activity of Maxell Pharma is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Maxell Pharma Private Limited, buy the company report.
Financials of Maxell Pharma Private Limited
FY 2025 filings availableMaxell Pharma Private Limited reported revenue of ₹6.92 Cr (up 52% YoY) for FY 2024.
Revenue · FY 2024
₹6.92 Cr ▲ 52%
Net profit · FY 2024
₹27.37 Lakh margin 4%
EBITDA · FY 2024
₹1.31 Cr margin 18.9%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▲ 52%
3 years · compounded
▲ 6%
5 years · compounded
▲ 5%
EBITDA CAGR growth
1 year
▲ 70%
5 years · compounded
▲ 11%
Revenue has grown at a compounded annual rate (CAGR) of 5% over five years, including 52% growth in the latest year. EBITDA rose 70% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹1.31 Cr | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹27.37 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 18.9% | ||||
| Net Profit Margin | 4% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Maxell Pharma Private Limited, buy the company report.
Board of directors of Maxell Pharma Private Limited
Maxell Pharma has 6 current directors and 2 former directors. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Madhuram Senthil Kumar Also directs: Royal Castle Property Developers Private Limited | Director | 21 Apr 2022 | 4 Years 6 Months | Current |
| Madhuram Udhaya Chander Also directs: Royal Castle Property Developers Private Limited | Director | 16 Apr 2010 | 16 Years 6 Months | Current |
| Takai Ali Bayas Ali Also directs: Mastro Biologicals Private Limited | Director | 16 Apr 2010 | 16 Years 6 Months | Current |
| Gnanasekaran Satheeshkumar | Director | 16 Apr 2010 | 16 Years 6 Months | Current |
| Shankar Subramanian | Managing Director | 16 Apr 2010 | 16 Years 6 Months | Current |
| Saravanan | Director | 16 Apr 2010 | 16 Years 6 Months | Current |
Auditor
Maxell Pharma Private Limited is audited by V. KRISHNAN AND CO for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| V. KRISHNAN AND CO | FY 2023 | 01541S |
Shareholding
The shareholding of Maxell Pharma Private Limited is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Maxell Pharma Private Limited, buy the company report.
Charges & borrowings
Open charges
₹4.61 Cr
Satisfied charges
None
Breakdown by lending institutions
Latest charge details
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 02 Mar 2023 | 100712811 | City Union Bank Limited | ₹2.79 Cr | Open | |
| 24 Dec 2021 | 100517192 | Others | ₹1.5 Cr | Open | |
| 29 Apr 2021 | 100452326 | Others | ₹32 Lakh | Open |
To see the full charge records of Maxell Pharma Private Limited, buy the company report.
Total charge records: 3 View all charges
Legal cases
Maxell Pharma Private Limited has 2 court cases on record: 2 filed against it. 1 case is pending and 1 is disposed.
Total cases
2
Filed against the company
2
Pending
1
Disposed
1
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 1 | 1 | 1 |
| High courts | 1 | 1 | 0 |
Cases on record (2 of 2)
| Court | Type of case | Party | Status |
|---|---|---|---|
| High Court of Delhi | Court case (CS(OS)) | Filed against the company by Ranbaxy Laboratories Ltd | Disposed |
| District court, Tiruvarur, Tamil Nadu | Criminal complaint | Filed against the company by State of Tamil Nadu Rep by Inspector of Police | Pending |
To see the full case history of Maxell Pharma Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Maxell Pharma Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Maxell Pharma has 1 GST registration: 1 active.
Total GSTINs
1
Active
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 33AAHCM1539L1ZD | Tamil Nadu | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Maxell Pharma Private Limited, buy the company report.
Recent activity
Maxell Pharma Private Limited has 8 board changes on record since 2010: 6 appointments and 2 cessations. The latest: Shankar Subramanian ceased to be Director on 31 Mar 2023.
AGM
Maxell Pharma Private Limited last Annual general meeting of members was held on 29 Sep 2025 as per latest MCA records.
Filing
Maxell Pharma Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Chennai.
Charges
A charge with City Union Bank Limited of Rs. 279.45 Lakh registered on 02 Mar 2023 with Charge ID 100712811 was modified on 06 Sep 2024.
Ceased
Shankar Subramanian ceased to be Director.
Charges
A charge with City Union Bank Limited amounted to Rs. 279.45 Lakh with Charge ID 100712811 was registered on 02 Mar 2023.
Ceased
Takai Ali Bayas Ali ceased to be Managing Director.
Appointed
Madhuram Senthil Kumar was appointed as Director.
Charges
A charge with Others amounted to Rs. 150.00 Lakh with Charge ID 100517192 was registered on 24 Dec 2021.
Charges
A charge with Others amounted to Rs. 32.00 Lakh with Charge ID 100452326 was registered on 29 Apr 2021.
Appointed
Gnanasekaran Satheeshkumar was appointed as Director.
Appointed
Madhuram Udhaya Chander was appointed as Director.
Appointed
Saravanan was appointed as Director.
3 earlier events are in the company report.
Frequently asked questions
Maxell Pharma is an active private limited company based in Sriperumbudur, Tamil Nadu, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 16 April 2010 (16+ years old) and is registered under CIN U24297TN2010PTC075380.
Maxell Pharma has 6 current directors:
- Shankar Subramanian - Managing Director
- Madhuram Senthil Kumar - Director
- Madhuram Udhaya Chander - Director
- Takai Ali Bayas Ali - Director
- Gnanasekaran Satheeshkumar - Director
- Saravanan - Director
The latest financial statements of Maxell Pharma on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 29 September 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of Maxell Pharma is 33AAHCM1539L1ZD, registered in Tamil Nadu.
The CIN (Corporate Identification Number) of Maxell Pharma is U24297TN2010PTC075380. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Maxell Pharma has 2 court cases on record: 2 filed against it. 1 is pending. Most are in the district courts.
Maxell Pharma was incorporated on 16 April 2010, making it 16+ years old. It is registered with the Registrar of Companies, Chennai.
Shankar Subramanian ceased to be Director on 31 Mar 2023. Takai Ali Bayas Ali ceased to be Managing Director on 28 Jan 2023. Madhuram Senthil Kumar was appointed as Director on 21 Apr 2022. Maxell Pharma has 8 board changes on record in total.
Yes, Maxell Pharma is registered as a small enterprise under Udyam registration (number: UDYAM-TN-30-0036296).
Maxell Pharma can be reached through the website maxellpharma.com. Its registered office is in Sriperumbudur, Tamil Nadu, India.